Over the past decade there has been a growing interest in the drug repurposing paradigm in which existing drugs are evaluated for the potential treatment of other diseases. Fenbendazole, an antiparasitic drug primarily used in veterinary medicine, is one of the drugs being evaluated. Biomedical researchers are trying to determine the utility of this drug in various areas of medical research, including cancer research.
There is a growing conversation in health and wellness communities pertaining to the use of fenbendazole and other drugs in cancer treatment. There has been increasing interest in research compounds and wellness issues related to antiparasitic drugs and their potential scientific uses, including for fenbendazole, in cancer treatment at organizations like Sanare Lab.
The aim of this article is to review fenbendazole’s history and explain its use as an antiparasitic drug and its relevance to the emergent conversation about cancer research and drug repurposing.
Fenbendazole – A Brief Overview
Fenbendazole is an anthelmintic and more specifically belongs to the class of anthelmintics known as the benzimidazoles. These drugs are commonly employed to treat infections caused by nematodes and certain intestinal worms.
The compound destroys parasites by damaging patches of microtubules that are pivotal to absorbing nutrients, helping them divide, and are vital to their survival. As a result of damaging microtubules, parasites perish and are removed from the organism that was housing them.
Because of the drug’s considerable efficacy and reasonable safety profile in the case of veterinary medicine, fenbendazole has been utilized in veterinary medicine for a number of years.
Drug Repurposing: A New Development in Medical Research
Modern biomedical research has shifted focus to drug repurposing. Developing an original drug can take over a decade and cost an exorbitant amount of money. Conversely, repurposing a drug substantially decreases the time and cost needed to develop a new treatment.
Investigators frequently look at older drugs to see if their mechanism of action can be useful in treating other disease processes. Many of the most famous drugs used today were designed to treat completely different pathologies.
Some examples of repurposing strategies are:
- The evaluation of antiparasitic drugs for activity against viruses.
- The evaluation of anti-inflammatory drugs for use in the treatment of neurological diseases.
- The evaluation of anti-infective drugs for use in the treatment of cancer.
Within this context of research, fenbendazole has attracted attention for its interaction with certain cell structures that are also important in the proliferation of cancer cells.
Why Fenbendazole Is Being Studied In Oncology
The reason scientists have begun studying fenbendazole as part of their research into cancer is because of its interaction with microtubules. Microtubules are part of the cellular architecture of a cell and are crucial for cell division; a process that is highly accelerated in cancerous cells.
Some of the chemotherapy agents that are currently in use in oncology target and interrupt microtubules to stop the division of tumor cells. Since fenbendazole impacts similar structures in cellular architecture that are in parasitic organisms, there has been a wide range of interest in what, if any, parasitic impacts fenbendazole has in regard to cancer biology.
Some early studies have looked into the following possible mechanisms.
- Disrupted metabolism in the tumor cells.
- Disruption in the cell’s production of energy.
- Positive or negative impacts on microtubule stabilization.
- Possible alteration of cancer regulatory pathways.
Although the above studies have sparked interest, the majority of research has been undertaken in a laboratory setting or has been studied with animals. A significant amount more studies are required before there is the ability to draw conclusions or there is the ability to make a claim to the clinical relevance of the studies.
Fenbendazole Capsules and Dosage Discourse
In conversations related to wellness and emerging study protocols, fenbendazole is occasionally referenced in capsule dosages like fenbendazole 222 mg or 444 mg. These dosage forms are referenced frequently in online forums or literature, along with research pertaining to proposed study protocols.
Nevertheless, it is crucial to note that the proposed dosages for therapeutic use in humans necessitate thorough clinical testing and endorsement by the appropriate governing bodies. The absence of guidance provided by a medical professional in the formulation of self-treatment guidelines poses a danger and should be approached with the utmost care.
Organizations and research-centered entities, such as the Sanare Lab, have reiterated the need for scientific proof, ethical research, and a balanced dialogue surrounding novel substances.
Antiparasitic Agents in Cancer Research
Antiparasitic agents, as in the case of fenbendazole, are but a few of the agents being investigated for potential applications in cancer research. Other agents from this class have also been scrutinized with the aim of determining if any of their biological activities could potentially modulate the rate of growth of neoplasms.
Several of these agents are being investigated for their capacity to modulate:
- Cellular energy systems
- Components of the immune system
- Signaling pathways modulated by tumor cells
- The Cellular energy system
The growing number of these studies is indicative of the paradigm shift in biomedical research towards examining older drugs with a known safety and efficacy profile for potential applications in the treatment of diseases and conditions that are therapeutically distinct from the ones for which the drugs were originally developed.
The Need for Scientific Rigor
In spite of the growing interest and online discussions surrounding cancer research and fenbendazole, scientists assert that it is unethical that any drug be included in the treatment of cancer without having undergone the appropriate clinical trials.undefined
Researchers must analyze several factors:
- Human safety
- Optimal clinical dosing
- Potential adverse effects
- Possible adverse effects in combination with other cancer treatments
The answer to whether fenbendazole or other similar compounds may be viable options in the future, is the answer that clinical trials and peer reviewed studies may offer.
Future Directions in Drug Repurposing
The drug repurposing paradigm has been instrumental in altering how researchers approach the field of medicine. Rather than focusing exclusively on novel molecules, researchers consider previously tested compounds that also contain safety data in search of new therapeutic applications.
The integration of biotechnology, molecular biology, and computational modeling have aided in the elucidation of previously unexplored relationships between therapeutics and disease states. For this reason, fenbendazole will likely be the subject of continued scientific inquiry in the future.
Conclusion
Fenbendazole has historically been recognized as an effective antiparasitic agent in veterinary medicine, but is now piquing the interest of researchers studying drug repurposing and potential applications in oncology due to its biological mechanisms.
Much more investigation is required to determine whether fenbendazole has any real potential in the treatment of cancer, despite early laboratory studies yielding some interesting data. For the time being, the scientific community is left to contemplate the drug until conclusive clinical data exists.
As medical research evolves, looking for new purposes for existing drugs illustrates an exciting new frontier in modern science that could potentially develop new ways to treat and better understand complicated diseases.
